Do health-status measures play a role in improving treatment in chronic obstructive pulmonary disease?

Author： van der Molen Thys   Kocks Jan Willem H  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.1, 2006-01, pp. : 57-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aclidinium bromide for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario   Page Clive P   Matera Maria Gabriella  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1205-1214

Informa Healthcare

Access to resources Recommend Favorite

Levosalbutamol for chronic obstructive pulmonary disease: a treatment evaluation

By Patel Manish   Thomson Neil C  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 7, 2012-05 ,pp. : 1069-1075

Informa Healthcare

Access to resources Recommend Favorite

Indacaterol maleate for the treatment of chronic obstructive pulmonary disease

By Tashkin Donald P  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 2077-2085

Informa Healthcare

Access to resources Recommend Favorite

Antiproteases and retinoids for treatment of chronic obstructive pulmonary disease

By Donnelly Louise E   Rogers Duncan F  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 9, 2003-09 ,pp. : 1345-1372

Informa Healthcare

Access to resources Recommend Favorite

Role of Adenosine Receptors in the Treatment of Asthma and Chronic Obstructive Pulmonary Disease: Recent Developments

By Maarten van den Berge  

Drugs in R&D, Vol. 8, Iss. 1, 2007-01 ,pp. : 13-23

Adis International

Access to resources Recommend Favorite